5 Comments
User's avatar
Tyler Corderman's avatar

Thank you.

Compounding Quality's avatar

It’s an honor, Tyler!

Payback Period Visuals's avatar

Excellent deep dive! The Buffett buy is a strong signal, but I wanted to add some quantitative rigor to the thesis. I ran 10,000 Monte Carlo DCF simulations on UNH:

β€’ Median intrinsic value: $546/share (~34% margin of safety at current ~$360)

β€’ P(undervalued): 87.6%

β€’ PEG ratio: 0.56 β€” pricing in far more risk than warranted

β€’ Moat probability (ROIC > WACC): 91.3%

The S-Curve analysis shows UNH at ~68% market penetration β€” still in growth phase, not maturity. Optum vertical integration is expanding the addressable market faster than consensus models.

Healthcare is at its lowest S&P weighting since 1994. That is a textbook contrarian signal for quality compounders like UNH.

Full quantitative valuation with Monte Carlo distributions: https://paybackperiod.substack.com/p/unitedhealth-unh-advanced-quantitative

Louis Duvoisin's avatar

Hi Pieter - I thought you had bought UNH based off of this article and another, however when I log into the portfolio I can’t see it, nor can I in your most recent round up of the portfolio performance. I just wanted to check whether you have invested in UNH, and whether the portfolio is yet to be updated, or have I missed something?

Apologies if this is a silly question!

Compounding Quality's avatar

Hi Louis,

UNH was actualy bought for Compounding Dividends, it’s our dividend service!